| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 603579 | 荣泰健康 | 35.33 | 5.31% | 9.79万 | | 3.37亿 | | 002614 | 喫佳化 | 6.71 | 0.45% | 5.42万 | | 3616.17万 | | 300247 | 融捷健康 | 4.26 | -0.23% | 32.92万 | | 1.39亿 | 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 从资金流向上来看，当日其他家电板块主力资金净流入593.02万元，游资资金净流入38.33万元，散户资 金净流出631.34万元。其他家电板块个股资金流向见下表： 证券之星消息，8月4日其他家电板块较上一交易日上涨2.6%，荣泰健康领涨。当日上证指数报收于 3583.31，上涨0.66%。深证成指报收于11041.56，上涨0.46%。其他家电板块个股涨跌见下表： | 代码 | | | 名称 ｜主力净流入 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 603579 | 荣泰健康 | 33.55 | 7.57% | 11.29万 | | 3.74 乙 | | 300247 | 融捷健康 | 4.27 | 1.91% | 42.45万 | | 1.79亿 | | 002614 | 奥佳华 | 6.68 | 1.52% | 7.97万 | | 5310.96万 | 从资金流向上来看，当日其他家电板块主力资金净流入2465.62万元，游资资金净流出1884.74万元，散 户资金净流出580.89万元。其他家电板块个股资金流向见下表： 证券之星消息，8月1日其他家电板块较上一交易日上涨4.47%，荣泰健康领涨。当日上证指数报收于 3559.95，下跌0.37%。深证成指报收于10991.32，下跌0.17%。其他家电板块个股涨跌见下表： 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 ...

| 代码 | | | 名称 │主力净流入（元）│主力净占比│游资净流入（元）│游资净占比│散户净流入（元）│散户净占比 | | | | | --- | --- | --- | --- | --- | --- | --- | | 300247 融捷健康 | 2147.81万 | 9.59% | -803.10万 | -3.59% | -1344.71万 | -6.01% | | 002614 | -1350.76万 | -20.98% | 552.04万 | 8.58% | 798.71万 | 12.41% | | 603579 荣泰健康 | -2483.94万 | -15.08% | 490.62万 | 2.98% | 1993.32万 | 12.10% | 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 300247 | 融捷健康 | 4.19 | 2.2 ...

从资金流向上来看，当日其他家电板块主力资金净流入3672.17万元，游资资金净流出1034.67万元，散户 资金净流出2637.5万元。其他家电板块个股资金流向见下表： 证券之星消息，7月29日其他家电板块较上一交易日上涨3.6%，荣泰健康领涨。当日上证指数报收于 3609.71，上涨0.33%。深证成指报收于11289.41，上涨0.64%。其他家电板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 603579 | 荣泰健康 | 31.95 | 7.68% | 12.90万 | 4.021Z | | 300247 | 融捷健康 | 4.11 | 0.74% | 21.22万 | 8659.51万 | | 002614 | 奥佳化 | 6.75 | -0.44% | 7.62万 | 5127.90万 | | 代码 | | | 名称 │主力净流入（元）│主力净占比│游资净流入（元）│游资净占比│散户净流入（元）│散户净占比 | | | | | --- | --- | --- | ...

Group 1 - The company received a letter from Founder Securities regarding the replacement of the continuous supervision sponsor representative due to the departure of Mr. Cao Fangyi [1] - Mr. Jiang Zhuocheng has been appointed as the new sponsor representative to continue the supervision of the company's publicly issued convertible bonds [1] - The continuous supervision period will last until the obligations set by the China Securities Regulatory Commission and Shenzhen Stock Exchange are fulfilled [1] Group 2 - The board of directors expressed gratitude for Mr. Cao Fangyi's contributions during his tenure as the sponsor representative [2] - Mr. Jiang Zhuocheng holds a Master's degree in International Business from Southwest University of Finance and Economics and has extensive experience in investment banking since 2021 [3] - His qualifications include being a registered accountant, registered tax agent, and holding a legal professional qualification [3]

| 证券代码：002614 | 股票简称：奥佳华 | 公告编号：2025-29 | 号 | | --- | --- | --- | --- | | 债券代码：128097 | 债券简称：奥佳转债 | | | 奥佳华智能健康科技集团股份有限公司 关于变更持续督导保荐代表人的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 公司董事会对曹方义先生在担任公司保荐代表人及持续督导期间所做出的 贡献表示衷心的感谢！ 特此公告。 奥佳华智能健康科技集团股份有限公司 董 事 会 2025 年 7 月 21 日 附件：保荐代表人蒋卓成先生简历 蒋卓成：西南财经大学国际商务硕士，保荐代表人，取得注册会计师、注册 税务师、法律职业资格。2021 年开始从事投资银行业务，先后主持或参与了索 通发展（603612.SH）、中矿资源（002738.SZ）非公开发行，甬矽电子（688362.SH） IP0，梦网科技（002123.SZ）重大资产重组，具有丰富的投资银行业务从业经验。 奥佳华智能健康科技集团股份有限公司（以下简称"公司"）于今日收到方 正证券承销保荐有限责任公司（以下简 ...

Core Viewpoint - The foot massage device industry is experiencing growth driven by increasing health awareness, an aging population, and technological advancements, with the market size expected to reach 446 million yuan in 2024, a year-on-year increase of 6.01% [1][11]. Industry Overview - Foot massage devices are designed to stimulate and relax foot muscles and acupoints, improving fatigue relief, sleep quality, and blood circulation [3][11]. - The industry is supported by a growing elderly population in China, providing a substantial user base for foot massage devices [1][11]. Market Dynamics - The rapid development of e-commerce has made online sales channels a significant direction for foot massage device sales, with platforms like JD.com, Tmall, and Douyin being major contributors [9]. - The e-commerce transaction volume in China is projected to grow from 33.87 trillion yuan in 2019 to 46.41 trillion yuan in 2024, benefiting the foot massage device industry [9]. Competitive Landscape - The foot massage device industry features a diverse competitive landscape, including international brands like Panasonic and domestic leaders such as Beileisong, Aojiahua, and Rongtai Health, alongside numerous small and medium enterprises [13][14]. Industry Chain - The industry chain consists of upstream suppliers providing components and materials, midstream manufacturers producing various types of foot massage devices, and downstream sales channels including online platforms and physical stores [6]. Development Trends - Future trends in the foot massage device industry include the integration of smart features for personalized health monitoring and remote medical guidance [18]. - Customization services are emerging to meet the diverse needs of different consumer groups, enhancing user satisfaction and product competitiveness [19]. Market Demand - There is a growing recognition of proactive health management, leading to increased demand for foot massage devices as tools for muscle relaxation and blood circulation improvement [21].

Core Viewpoint - OgaHua is facing significant challenges in its business performance, particularly in the massage chair segment, with declining revenues and increasing operational pressures due to reliance on overseas markets and changing consumer demand [1][2][3]. Financial Performance - OgaHua's revenue has declined from approximately 60.24 billion in 2022 to about 50.3 billion in 2023, with Q1 2023 revenue at around 10.51 billion, representing an 11.15% year-on-year decrease [1][2]. - The company reported a net profit of approximately 499.7 million in Q1 2023, largely due to non-operating income, while the adjusted net profit showed a loss of about 996 million, marking the first loss in three years [2]. Market Dynamics - The massage chair market is currently facing a downturn, with OgaHua lagging behind competitors like Rongtai Health, which reported a slight revenue increase of 3.86% in Q1 2023 [2]. - OgaHua's international sales accounted for 68.94% of its total revenue, with significant reliance on markets in Europe, North America, and Southeast Asia, which are currently experiencing weak demand [2][3]. Strategic Initiatives - OgaHua plans to expand its market presence in countries along the "Belt and Road" initiative and enhance its cross-border e-commerce channels to mitigate current challenges [4]. - The company is also focusing on diversifying its product offerings beyond massage chairs to include health-related appliances, which previously helped maintain revenue during the pandemic [6]. Operational Challenges - The marketing pressure for massage chairs is high due to their non-essential nature and high price points, leading to longer consumer decision-making processes [5]. - OgaHua is reducing operational costs, with sales expenses down by 2.47% and R&D expenses down by 9.57% in 2023, indicating a need to manage financial strain amid declining revenues [4].

Core Viewpoint - The company has decided not to adjust the conversion price of its convertible bonds, despite triggering conditions for a downward adjustment due to stock prices falling below 85% of the current conversion price [2][6][15] Group 1: Board Meeting and Decisions - The sixth board meeting was held on July 4, 2025, where all nine directors participated and confirmed the meeting's legitimacy [1][2] - The board unanimously approved the proposal not to adjust the conversion price of the "Aojia Convertible Bonds" [2][6] Group 2: Convertible Bond Details - The current conversion price of the "Aojia Convertible Bonds" is 9.35 yuan per share, and the stock price has been below 7.95 yuan for fifteen consecutive trading days, triggering the adjustment clause [6][15] - The company issued 12 million convertible bonds on February 25, 2020, with a total value of 120 million yuan [6][8] - The bonds were listed on the Shenzhen Stock Exchange on March 18, 2020, under the code "128097" [7] Group 3: Conversion Price Adjustment History - The conversion price has been adjusted multiple times due to profit distribution, with the most recent adjustment reducing the price from 9.45 yuan to 9.35 yuan on May 29, 2025 [10][12] - The company has a defined process for adjusting the conversion price, which requires board approval and shareholder voting [13][14]

| 证券代码：002614 | 股票简称：奥佳华 | 公告编号：2025-28 | 号 | | --- | --- | --- | --- | | 债券代码：128097 | 债券简称：奥佳转债 | | | 奥佳华智能健康科技集团股份有限公司 关于不向下修正奥佳转债转股价格的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、截至 2025 年 7 月 4 日，公司股票已有十五个交易日的收盘价低于当期转 股价格 9.35 元/股的 85%的情形，已触发"奥佳转债"转股价格的向下修正条件。 2、公司于 2025 年 7 月 4 日召开第六届董事会第九次会议，审议通过了《关 于不向下修正"奥佳转债"转股价格的议案》，公司董事会决定本次不向下修正 "奥佳转债"转股价格，且在未来六个月内（即 2025 年 7 月 5 日至 2026 年 1 月 4 日），如再次触发"奥佳转债"转股价格向下修正条款，亦不提出向下修正 方案。从 2026 年 1 月 5 日重新起算，若再次触发"奥佳转债"转股价格向下修 正条款，届时公司董事会将再次召开会议决定是否行使" ...